

Pretomanid Tablets
Hongqi pharmaceutical
Quick Info
tuberculosis
This product is an antimycobacterial drug indicated as part of a combination therapy with bedaquiline and linezolid for the treatment of adult patients with pulmonary tuberculosis (TB) resistant to isoniazid, rifamycins, any fluoroquinolone, and any second-line injectable anti-TB drug, or resistant to isoniazid and rifampicin who are intolerant or unresponsive to standard treatment. This indication is approved based on limited clinical safety and efficacy data. This product is only indicated for limited and specific patient populations.
200mg
This product can only be used in combination with bedaquiline and linezolid as part of combination therapy.
This product should be administered and monitored by a physician experienced in treating multidrug-resistant tuberculosis.
The importance of full treatment compliance should be emphasized to patients.
This product should be used in combination with bedaquiline and linezolid under directly supervised treatment (DOT).
The safety and efficacy of this product as part of a combination therapy with other drugs other than bedaquiline and linezolid have not been established. Therefore, this product should not be used as part of other combination therapy regimens. This product is used as part of a combination therapy with bedaquiline and linezolid. For more risk information, please refer to the instructions for bedaquiline and linezolid. The precautions related to bedaquiline and linezolid also apply to their combination therapy with this product.
Medicine

Etoposide Injection
Mainly used to treat small cell lung cancer, malignant lymphoma, malignant germ cell tumor, leukemia, neuroblastoma, rhabdomyosarcoma, ovarian cancer, non-small...
1-1.png)
Sintilimab Injection
Classical Hodgkin's lymphoma, Non-squamous non-small cell lung cancer, Squamous non-small cell lung cancer, Hepatocellular carcinoma, Esophageal squamous cell carcinoma, Gastric...

Apatinib Mesylate Tablets
This product is suitable for patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed or relapsed after...

Anlotinib Hydrochloride Capsules
Anlotinib is a new small molecule tyrosine kinase inhibitor of multi-targets, which acts effectively on targets such as VEGFR, PDGFR,...
Related News

China’s innovative drugs gain momentum in global expansion efforts

Virtual mental health care visits: Making them work for youChinese-made new drugs big hit overseasVirtual mental health care visits: Making them work for you

Accelerating Chinese Innovative Drugs Going Global: International New Drug R&D Regulation Forum Successfully Held